Sanjay Gurunathan Email & Phone Number | Physician scientist with 23 years of global vaccine development experience at Sanofi Vaccines with the primary responsibility to ensure the effective, timely, and robust design and management of Sanofi Vaccines clinical programs. Manage a large international multi-disciplinary team located in France, North and South America and Asia by providing medical and scientific leadership and overseeing Phase I – IV clinical trial activities for novel vaccine targets and the support of vaccine life cycle management and epidemiological activities worldwide. Currently oversee a department of approx. 250 personnel including clinical development and strategy, study management, medical writing, biostatistical and data sciences with a strong track record in implementing Sanofi Vaccines business and strategic objectives into Clinical R&D plans and success Career Achievements •Active contribution in defining R&D strategy/vision for Sanofi Pasteur and aligning company and R&D strategic goals with clinical strategy •Lead successful regulatory submissions with over 20 successful Approvals (FDA, EMA, and other international approvals) •Hands-on leadership of successful implementation and completion of 8 large multinational Phase III efficacy studies, including recent COVID 19 vaccine studies •Authored over 50 scientific publications •Lead several change management initiatives •Proven track record of hiring and retaining international talent •Participated in several due diligence efforts for mergers and acquisitions, including recent mRNA technology partnerships

Sanjay Gurunathan

Physician scientist with 23 years of global vaccine development experience at Sanofi Vaccines with t...
Bethlehem, Pennsylvania, United States

*50 free lookup(s) per month.

No credit card required.

Sanjay Gurunathan’s Email sanjay.gurunathan@sanofipasteur.com

Sanjay Gurunathan’s Phone Numbers

Get SANJAY’s Phone Number (For Free)

Social Media

Sanjay Gurunathan’s Location Bethlehem, Pennsylvania, United States

Sanjay Gurunathan’s Current Industry Sanofi Vaccines

Sanjay Gurunathan’s Prior Industry Niaid Nih Bethesda

Not the Sanjay Gurunathan you were looking for?

Find accurate emails & phone numbers for over 700M professionals.

Work Experience

Sanofi Vaccines

Vice President , Head Global Clinical Development

2018-01-01 00:00:00 - Present

Niaid Nih Bethesda

Senior Staff Fellow

1993-01-01 00:00:00 - 2000-01-01 00:00:00

Skills

No Skills Available

Languages

No Languages Available

FAQ About Sanjay Gurunathan

Sanjay Gurunathan is located at
Bethlehem, Pennsylvania, United States

Sanjay Gurunathan is a Physician scientist with 23 years of global vaccine development experience at Sanofi Vaccines with the primary responsibility to ensure the effective, timely, and robust design and management of Sanofi Vaccines clinical programs. Manage a large international multi-disciplinary team located in France, North and South America and Asia by providing medical and scientific leadership and overseeing Phase I – IV clinical trial activities for novel vaccine targets and the support of vaccine life cycle management and epidemiological activities worldwide. Currently oversee a department of approx. 250 personnel including clinical development and strategy, study management, medical writing, biostatistical and data sciences with a strong track record in implementing Sanofi Vaccines business and strategic objectives into Clinical R&D plans and success Career Achievements •Active contribution in defining R&D strategy/vision for Sanofi Pasteur and aligning company and R&D strategic goals with clinical strategy •Lead successful regulatory submissions with over 20 successful Approvals (FDA, EMA, and other international approvals) •Hands-on leadership of successful implementation and completion of 8 large multinational Phase III efficacy studies, including recent COVID 19 vaccine studies •Authored over 50 scientific publications •Lead several change management initiatives •Proven track record of hiring and retaining international talent •Participated in several due diligence efforts for mergers and acquisitions, including recent mRNA technology partnerships